The FDA letter noted multiple Philips defibrillator problems, such as an issue with detached or missing magnets that has generated 87 complaints since early 2008, including one patient death. The FDA said Philips's responses missed the mark because "they do not address the quality system observation indicating that no evaluation of the effectiveness of the corrective action was performed or documented."
FDA Announcement
Posted 4/1/2011
